       Document 0093
 DOCN  M9610093
 TI    [Costs of safety of blood and blood products]
 DT    9601
 AU    Seifried E; Soedel G; Institut fur Transfusionsmedizin und
       Immunohamatologie,; Blutspendedienst Hessen des DRK Frankfurt am Main.
 SO    Zentralbl Chir. 1995;120(8):584-92. Unique Identifier : AIDSLINE
       MED/96041005
 AB    The safety of blood and blood components in transfusion medicine has
       become a very important factor. While diagnostic and therapeutic medical
       procedures need an increasing amount of special blood products,
       increasing demands on safety result in a reduction of blood donations.
       Considerable costs are caused by the requirement of self-sufficiency,
       additional assays to detect virus infections such as HIV, HCV and
       others, virus inactivation of blood and plasma, storing of plasma in
       quarantine, increase of autologous blood donation, and a great many of
       further steps to improve the safety in transfusion medicine. To obtain
       absolute safety, efforts are required that necessarily exceed the
       financial capacity of our health system. Because of budget limitations
       increasing costs of blood products will interfere with progress of other
       areas of health care. In addition ethical aspects of the use of funds
       have to be taken into consideration.
 DE    Blood Component Transfusion/*ECONOMICS  Blood Donors/SUPPLY &
       DISTRIBUTION  Blood Transfusion/*ECONOMICS  *Blood-Borne Pathogens
       Cost-Benefit Analysis/TRENDS  English Abstract  Forecasting  Germany
       Human  HIV Infections/ECONOMICS/PREVENTION & CONTROL/TRANSMISSION  Mass
       Screening/*ECONOMICS  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

